Intertek launches comprehensive inhalation product development services

Intertek is pleased to announce the launch of comprehensive services for orally inhaled and intra-nasal drug products (OINDPs).

Following the acquisition of Melbourn Scientific, Intertek are able to offer a unique development, formulation and characterisation service to its clients who are looking to deliver both biomolecules as well as traditional small molecule drug products.

Through centers of excellence, Intertek can offer an integrated service solution covering formulation,  analytical method development and validation, drug product physical characterisation, extractables / leachables, Chemistry, Manufacturing and Controls (CMC) support, Stability studies and QC release testing. Intertek experts also provide regulatory affairs consultancy, bioanalysis and extractables and leachables studies for all types of inhalation medicine products.

 

Read full article.

For our full pharmaceutical services, please visit us online or contact us

____________________________________



Read more

Looking for something specific?